Shlomo Shibolet
Tel Aviv University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Shlomo Shibolet.
Leukemia Research | 1991
Rita Michalevicz; Reuven Porat; Michal Vechoropoulos; Shoshana Baron; Miriam Yanoov; Zwi Cycowitz; Shlomo Shibolet
Hematopoiesis was evaluated in 15 B-CLL patients using the mixed colony formation assay. The mean growth of all types of colonies in B-CLL peripheral blood was significantly lower than that of 10 normal controls (p less than 0.05). To investigate whether TNF is the cytokine involved in the reduced growth of hematopoietic progenitors in B-CLL, neutralizing anti-TNF antibodies (anti-TNF Abs) were added to the cultures. Anti-TNF Abs optimized in vitro hematopoiesis in 11 out of 15 B-CLL patients and a significant growth increase in all types of colonies was noted as compared to baseline cultures (p less than 0.05). In patients with stage IV disease, the increase in both mixed and erythroid colonies was more prominent than in patients with earlier disease stages. This optimization of growth was also observed in normal control cultures containing accessory cells. However, high TNF levels were measured in conditioned media from CLL patients and suppressed normal bone marrow hematopoietic progenitors growth. In contrast no TNF was detected in normal conditioned media. It is concluded that TNF and other cytokines, among them IL-3, play a role in the regulation of hematopoietic function in some B-CLL cases. These findings may have clinical applicability.
International Journal of Dermatology | 1984
Michael Dan; Medina Jedwab; Michal Peled; Shlomo Shibolet
ABSTRACT: An erythematous eruption with itching developed in an 84‐year‐old man 4 days after therapy with allopurinol was initiated. The diagnosis of toxic epidermal necrolysis, suspected when separation of the epidermis was noted, was confirmed by skin biopsy. This is the third reported case that can be attributed exclusively to allopurinol and the first patient who did not die.
Annals of Internal Medicine | 1975
Shlomo Shibolet; Zvi Farfel
Excerpt To the editor: In their letter Cornell and colleagues (1) express the view that disseminated intravascular dissemination rather than primary fibrinolysis contributes to the morbidity and mo...
JAMA Internal Medicine | 1978
Zvi Farfel; Adrian Iaina; Talma Rosenthal; Uzi Waks; Shlomo Shibolet; Joseph Gafni
Annals of Internal Medicine | 1966
Joseph Gafni; Hans-Joachim Merker; Shlomo Shibolet; Ezra Sohar; Harry Heller
The Journal of Infectious Diseases | 1992
Reuven Porat; Ronnen Mosseri; Eliezer Kaplan; Margaret Johns; Shlomo Shibolet
Chest | 1979
Shlomo Shibolet; Michael Dan; Medina Jedwab; Yochanan Goldhammer; Gerald L. Baum
JAMA Internal Medicine | 1968
Ezra Sohar; Dan Michaeli; Uzi Waks; Shlomo Shibolet
Nature | 1966
Hans-Joachim Merker; Shlomo Shibolet; Ezra Sohar; Joseph Gafni; Harry Heller
JAMA Internal Medicine | 1982
Michael Dan; Simon Bar-Meir; Medina Jedwab; Shlomo Shibolet